Cellular Biomedicine Group, Inc.
CBMG
CBMG was delisted on the 19th of February, 2021.
45 hedge funds and large institutions have $30M invested in Cellular Biomedicine Group, Inc. in 2015 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 7 closing their positions.
329% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 7
167% more capital invested
Capital invested by funds: $11.2M → $30M (+$18.8M)
105% more funds holding
Funds holding: 22 → 45 (+23)
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$8.32M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$2.97M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.48M |
| 4 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$1.12M |
| 5 |
Bank of New York Mellon
New York
|
+$912K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
-$2.96M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$1.53M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$958K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$669K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$403K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VKH
51
Virtu KCG Holdings
New York
| – | -$267K | -8,487 | Closed |
|
52
Renaissance Technologies
New York
| – | -$258K | -8,200 | Closed |
|
CBMG Hedge Fund Activity: Q2 2015 in Review
45 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Cellular Biomedicine Group, Inc. (CBMG) for Q2 2015, worth a combined $30M — up 167% from $11.2M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new CBMG positions and 7 closed out — a net gain of 23 holders — while 7 added to existing stakes and 6 trimmed.
The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $8.32M. The largest seller was JP Morgan Private Wealth Advisors, exiting entirely with an estimated $2.96M sold.
- 45 institutional investors held Cellular Biomedicine Group, Inc. (CBMG) as of Q2 2015, up from 22 in Q1 2015.
- Funds reported $30M of Cellular Biomedicine Group, Inc. stock for Q2 2015, up 167% quarter-over-quarter.
- 30 funds opened new Cellular Biomedicine Group, Inc. positions in Q2 2015 and 7 closed out, a net change of +23 holders.
- The largest Cellular Biomedicine Group, Inc. buyer in Q2 2015 was BlackRock Fund Advisors, an estimated $8.32M added.
- The largest Cellular Biomedicine Group, Inc. seller in Q2 2015 was JP Morgan Private Wealth Advisors, an estimated $2.96M sold.
Based on aggregated 13F filings for Q2 2015.